223 related articles for article (PubMed ID: 18582173)
1. Papanicolaou testing among women in the southern United States.
Peterson NB; Murff HJ; Cui Y; Hargreaves M; Fowke JH
J Womens Health (Larchmt); 2008; 17(6):939-46. PubMed ID: 18582173
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
Hewitt M; Devesa SS; Breen N
Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
[TBL] [Abstract][Full Text] [Related]
3. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
4. Utilization of papanicolaou smears by South Asian women living in the United States.
Chaudhry S; Fink A; Gelberg L; Brook R
J Gen Intern Med; 2003 May; 18(5):377-84. PubMed ID: 12795737
[TBL] [Abstract][Full Text] [Related]
5. Screening for Cervical Cancer and Sexually Transmitted Diseases Among HIV-Infected Women.
Frazier EL; Sutton MY; Tie Y; McNaghten AD; Blair JM; Skarbinski J
J Womens Health (Larchmt); 2016 Feb; 25(2):124-32. PubMed ID: 26447835
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women.
Hirth JM; Laz TH; Rahman M; Berenson AB
J Womens Health (Larchmt); 2016 Apr; 25(4):371-80. PubMed ID: 26579735
[TBL] [Abstract][Full Text] [Related]
7. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
[TBL] [Abstract][Full Text] [Related]
8. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth.
Hewitt M; Devesa S; Breen N
Am J Public Health; 2002 Apr; 92(4):666-9. PubMed ID: 11919069
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
10. Cervical cancer screening in the US-Mexico border region: a binational analysis.
Herrera DG; Schiefelbein EL; Smith R; Rojas R; Mirchandani GG; McDonald JA
Matern Child Health J; 2012 Dec; 16 Suppl 2(0 2):298-306. PubMed ID: 22965734
[TBL] [Abstract][Full Text] [Related]
11. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
Benard VB; Lee NC; Piper M; Richardson L
Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
[TBL] [Abstract][Full Text] [Related]
12. The frequency of Pap smear screening in the United States.
Sirovich BE; Welch HG
J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
[TBL] [Abstract][Full Text] [Related]
13. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
14. Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women's Health Across the Nation (SWAN).
Jacobs EA; Rathouz PJ; Karavolos K; Everson-Rose SA; Janssen I; Kravitz HM; Lewis TT; Powell LH
J Womens Health (Larchmt); 2014 Feb; 23(2):138-45. PubMed ID: 24261647
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic predictors of adherence to annual cervical cancer screening in minority women.
Jennings-Dozier K; Lawrence D
Cancer Nurs; 2000 Oct; 23(5):350-6; quiz 357-8. PubMed ID: 11037955
[TBL] [Abstract][Full Text] [Related]
16. Case management intervention in cervical cancer prevention: the Boston REACH coalition women's health demonstration project.
Clark CR; Baril N; Hall A; Kunicki M; Johnson N; Soukup J; Lipsitz S; Bigby J
Prog Community Health Partnersh; 2011; 5(3):235-47. PubMed ID: 22080772
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening: who is not screened and why?
Harlan LC; Bernstein AB; Kessler LG
Am J Public Health; 1991 Jul; 81(7):885-90. PubMed ID: 2053665
[TBL] [Abstract][Full Text] [Related]
18. Physician recommendation for papanicolaou testing among U.S. women, 2000.
Coughlin SS; Breslau ES; Thompson T; Benard VB
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
Sumarmi S; Hsu YY; Cheng YM; Lee SH
Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
Katz SJ; Hofer TP
JAMA; 1994 Aug; 272(7):530-4. PubMed ID: 8046807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
